Financial News
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
3,827 articles
📰
Prediction: 2 Stocks That Will Be Worth More Than Summit Therapeutics 1 Year From Now
The next 10 months might be challenging for this biotech.
📰
Precigen (PGEN) Q4 2025 Earnings Call Transcript
Image source: The Motley Fool.Wednesday, March 25, 2026 at 4:30 p.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading
12 Communication Services Stocks Moving In Wednesday's After-Market Session
Gainers
Beasley Broadcast Group (NASDAQ:BBGI) shares moved upwards by 10.8% to $4.09 during Wednesday's after-market session. The market value...
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
Healthcare Triangle (NASDAQ:HCTI) stock increased by 41.1% to $4.12 during Wednesday's after-market session. The company's market...
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
Healthcare Triangle (NASDAQ:HCTI) stock increased by 41.1% to $4.12 during Wednesday's after-market session. The company's market...
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
Healthcare Triangle (NASDAQ:HCTI) stock increased by 41.1% to $4.12 during Wednesday's after-market session. The company's market...
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
Healthcare Triangle (NASDAQ:HCTI) stock increased by 41.1% to $4.12 during Wednesday's after-market session. The company's market...
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
Healthcare Triangle (NASDAQ:HCTI) stock increased by 41.1% to $4.12 during Wednesday's after-market session. The company's market...
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
Healthcare Triangle (NASDAQ:HCTI) stock increased by 41.1% to $4.12 during Wednesday's after-market session. The company's market...
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
Healthcare Triangle (NASDAQ:HCTI) stock increased by 41.1% to $4.12 during Wednesday's after-market session. The company's market...
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
Healthcare Triangle (NASDAQ:HCTI) stock increased by 41.1% to $4.12 during Wednesday's after-market session. The company's market...
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
Healthcare Triangle (NASDAQ:HCTI) stock increased by 41.1% to $4.12 during Wednesday's after-market session. The company's market...
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
Healthcare Triangle (NASDAQ:HCTI) stock increased by 41.1% to $4.12 during Wednesday's after-market session. The company's market...
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
Healthcare Triangle (NASDAQ:HCTI) stock increased by 41.1% to $4.12 during Wednesday's after-market session. The company's market...
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
Healthcare Triangle (NASDAQ:HCTI) stock increased by 41.1% to $4.12 during Wednesday's after-market session. The company's market...
📰
Top Stock Reports for Amazon.com, TJX and Eaton Corp.
Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), The TJX Companies, Inc. (TJX) and Eaton...
📰
Rani Therapeutics Appoints Jesper Høiland as Head of Strategy to Advance Corporate and Pipeline Prioritization
SAN JOSE, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. ("Rani Therapeutics" or "Rani") (NASDAQ:RANI), a...
📰
Rani Therapeutics Appoints Jesper Høiland as Head of Strategy to Advance Corporate and Pipeline Prioritization
SAN JOSE, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a...
📰
Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress
Commercial launch of AlbuFree™ DX recombinant human albumin by Proliant Health & Biologicals using Dyadic's production platform, with...
📰
Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress
DYADIC ANNOUNCES 2025 FINANCIAL RESULTS AND HIGHLIGHTS RECENT COMPANY PROGRESS
TELA Bio Analysts Cut Their Forecasts After Q4 Results
TELA Bio, Inc. (NASDAQ:TELA) reported mixed results for the fourth quarter on Tuesday.
The company posted quarterly losses of 17 cents per share...
📰
Why Investors Strapped a Rocket to Corcept Therapeutics Stock on Wednesday
A top regulator approved one of its drugs that afternoon.
📰
NMRA Investors Have Opportunity to Join Neumora Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES, March 25, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is...
📰
Planet 13 Announces Q4 2025 Financial Results
All results are reported in United States dollars ($) unless otherwise indicated.
Innovative Eyewear Inc. Reports Full Year 2025 Financial Results
Revenue increased 63% over prior year
Gross Profit Margins increased by 8 percentage points despite tariff headwinds
MIAMI, March 25, 2026...
📰
Planet 13 Announces Q4 2025 Financial Results
●
Q4 2025 Revenue of $25.2 million
●
Q4 2025 Net loss of $4.6 million
●
Q4 2025 Adjusted EBITDA loss of $0.3 million
All results...
Innovative Eyewear Inc. Reports Full Year 2025 Financial Results
Revenue increased 63% over prior year
Gross Profit Margins increased by 8 percentage points despite tariff headwinds
MIAMI, March 25, 2026...
📰
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Atara Biotherapeutics, Inc. (ATRA)
NEW YORK, March 25, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the...
Devonian Health Group Inc. Reports Financial and Operating Results of its Three and Six Months Ended January 31, 2026
(all amounts are in Canadian dollars) Quarter ended January 31, 2026, net loss of $2.2 million dollars, ($0.81) per share Six months ended January...
Devonian Health Group Inc. Reports Financial and Operating Results of its Three and Six Months Ended January 31, 2026
(all amounts are in Canadian dollars)
Quarter ended January 31, 2026, net loss of $2.2 million dollars, ($0.81) per share
Six months ended January...
📰
Exicure, Inc. Reports Full Year 2025 Financial Results
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"...
📰
Exicure, Inc. Reports Full Year 2025 Financial Results
Exicure, Inc. Reports Full Year 2025 Financial Results
📰
Exicure, Inc. Reports Full Year 2025 Financial Results
Exicure, Inc. Reports Full Year 2025 Financial Results